Template:ID-infections-by-organ-system: Difference between revisions

VisualWikitext

Revision as of 21:31, 2 June 2015

Cardiovascular

Aortitis, infectious ⇧ Return to Top ⇧

Cardiovascular implantable electronic device infections ⇧ Return to Top ⇧

Endocarditis

Endocarditis, prophylaxis ⇧ Return to Top ⇧

Endocarditis, treatment ⇧ Return to Top ⇧

Infective endocarditis^[1]

Culture-negative endocarditis

Culture-negative, native valve endocarditis

Preferred regimen: Ampicillin-sulbactam 12 g/24h IV q6h 4–6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 4–6 weeks
Alternative regimen: Vancomycin 30 mg/kg/24h IV q12h for 4–6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 4–6 weeks AND Ciprofloxacin 1000 mg/24h PO or 800 mg/24h IV q12h for 4–6 weeks
Pediatric dose: Ampicillin-sulbactam 300 mg/kg/24h IV q4–6h; Gentamicin 3 mg/kg/24h IV/IM q8h; Vancomycin 40 mg/kg/24h q8–12h; Ciprofloxacin 20–30 mg/kg/24h IV/PO q12h

Culture-negative, prosthetic valve endocarditis (early, ≤ 1 year)

Preferred regimen : Vancomycin 30 mg/kg/24h IV q12h for 6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 2 weeks AND Cefepime 6 g/24h IV q8h for 6 weeks AND Rifampin 900 mg/24h PO/IV q8h for 6 weeks
Pediatric dose: Vancomycin 40 mg/kg/24h IV q8–12h; Gentamicin 3 mg/kg/24h IV/IM q8h; Cefepime 150 mg/kg/24h IV q8h; Rifampin 20 mg/kg/24h PO/IV q8h

Culture-negative, prosthetic valve endocarditis (late, > 1 year)

Preferred regimen: Ampicillin-sulbactam 12 g/24h IV q6h 6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 6 weeks
Alternative regimen: Vancomycin 30 mg/kg/24h IV q12h for 4–6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 6 weeks AND Ciprofloxacin 1000 mg/24h PO or 800 mg/24h IV q12h for 6 weeks
Pediatric dose: Ampicillin-sulbactam 300 mg/kg/24h IV q4h; Gentamicin 3 mg/kg/24h IV/IM q8h; Vancomycin 40 mg/kg/24h q8–12h; Ciprofloxacin 20–30 mg/kg/24h IV/PO q12h

Culture-negative, prosthetic valve endocarditis (early, ≤ 1 year)

Preferred regimen: Ampicillin-sulbactam 12 g/24h IV q6h 4–6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 4–6 weeks AND Rifampin 900 mg/24h PO/IV q8h for 6 weeks
Alternative regimen: Vancomycin 30 mg/kg/24h IV q12h for 4–6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 4–6 weeks AND Ciprofloxacin 1000 mg/24h PO or 800 mg/24h IV q12h for 4–6 weeks AND Rifampin 900 mg/24h PO/IV q8h for 6 weeks
Pediatric dose: Ampicillin-sulbactam 300 mg/kg/24h IV q4–6h; Gentamicin 3 mg/kg/24h IV/IM q8h; Vancomycin 40 mg/kg/24h IV q8–12h; Cefepime 150 mg/kg/24h IV q8h; Rifampin 20 mg/kg/24h PO/IV q8h

Pathogen-directed antimicrobial therapy

Bartonella

Suspected Bartonella endocarditis

Preferred regimen : Ceftriaxone sodium 2 g/24h IV/IM in 1 dose for 6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 2 weeks ± Doxycycline 200 mg/kg/24h IV/PO q12h for 6 weeks
Pediatric dose: Ceftriaxone 100 mg/kg/24h IV/IM once daily; Gentamicin 3 mg/kg/24h IV/IM q8h; Doxycycline 2–4 mg/kg/24h IV/PO q12h; Rifampin 20 mg/kg/24h PO/IV q12h

Documented Bartonella endocarditis

Preferred regimen: Doxycycline 200 mg/24h IV or PO q12h for 6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 2 weeks
Pediatric dose: Ceftriaxone 100 mg/kg/24h IV/IM once daily; Gentamicin 3 mg/kg/24h IV/IM q8h; Doxycycline 2–4 mg/kg/24h IV/PO q12h; Rifampin 20 mg/kg/24h PO/IV q12h

Enterococcus

Endocarditis caused by enterococcal strains susceptible to penicillin, gentamicin, and vancomycin

Preferred regimen : Ampicillin 12 g/24h IV q4h for 4–6 weeks OR Penicillin G 18–30 million U/24h IV either continuously or q4h for 4–6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 4–6weeks
Alternative regimen : Vancomycin 30 mg/kg/24h IV q12h for 6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 6 weeks
Pediatric dose: Vancomycin 40 mg/kg/24h IV q8–12h; Gentamicin 3 mg/kg/24h IV/IM q8h

Endocarditis caused by enterococcal strains susceptible to penicillin, streptomycin, and vancomycin and resistant to gentamicin

Preferred regimen : Ampicillin 12 g/24h IV q4h for 4–6 weeks OR Penicillin G 24 million U/24h IV continuously or q4h for 4–6 weeks AND Streptomycin 15 mg/kg/24h IV/IM q12h for 4–6 weeks
Alternative regimen : Vancomycin 30 mg/kg/24h IV q12h for 6 weeks AND Streptomycin 15 mg/kg/24h IV/IM q12h for 6 weeks
Pediatric dose: Ampicillin 300 mg/kg/24h IV q4–6h; Penicillin 300 000 U/kg/24h IV q4–6h; Streptomycin 20–30 mg/kg/24h IV/IM q12h; Vancomycin 40 mg/kg/24h IV q8–12h; Streptomycin 20–30 mg/kg/24h IV/IM q12h

Endocarditis caused by enterococcal strains resistant to penicillin and susceptible to aminoglycoside and vancomycin

β-Lactamase–producing strain

Preferred regimen: Ampicillin-sulbactam 12 g/24h IV q6h for 6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 6 weeks
Alternative regimen : Vancomycin 30 mg/kg/24h IV q12h for 6 weeks
Pediatric dose: Ampicillin-sulbactam 300 mg/kg/24h IV q6h; Gentamicin 3 mg/kg/24h IV/IM q8h

Intrinsic penicillin resistance

Preferred regimen: Vancomycin 30 mg/kg/24h IV q12h for 6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8h for 6 weeks
Pediatric dose: Vancomycin 40 mg/kg/24h IV q8–12h; Gentamicin 3 mg/kg/24h IV/IM q8h

Endocarditis caused by enterococcal strains resistant to penicillin, gentamicin, and vancomycin

Enterococcus faecium

Preferred regimen : Linezolid 1200 mg/24h IV/PO q12h for ≥ 8 weeks OR Quinupristin-Dalfopristin 22.5 mg/kg/24h IV q8h for 8 weeks

Enterococcus faecalis

Preferred regimen : Imipenem/cilastatin 2 g/24h IV q6h for ≥ 8 weeks AND Ampicillin 12 g/24h IV q4h for ≥ 8 weeks OR Ceftriaxone sodium 4 g/24h IV/IM q12h for ≥ 8 weeks AND Ampicillin 12 g/24h IV q4h for ≥ 8 weeks
Pediatric dose: Linezolid 30 mg/kg/24h IV/PO q8h; Quinupristin-Dalfopristin 22.5 mg/kg/24h IV q8h; Imipenem/cilastatin 60–100 mg/kg/24h IV q6h; Ampicillin 300 mg/kg/24h IV q4–6h; Ceftriaxone 100 mg/kg/24h IV/IM q12h

HACEK organisms

Endocarditis caused by Haemophilus, Aggregatibacter (Actinobacillus), Cardiobacterium, Eikenella corrodens, or Kingella

Preferred regimen : Ceftriaxone sodium 2 g/24h IV/IM in 1 dose for 4 weeks OR Ampicillin 12 g/24h IV q6h for 4 weeks OR Ciprofloxacin 1000 mg/24h PO or 800 mg/24h IV q12h for 4 weeks
Pediatric dose: Ceftriaxone 100 mg/kg/24h IV/IM once daily; Ampicillin-sulbactam 300 mg/kg/24h IV divided into 4 or 6 equally divided doses; Ciprofloxacin 20–30 mg/kg/24h IV/PO q12h

Staphylococcus

Native valve endocarditis caused by oxacillin-susceptible staphylococci

Preferred regimen (1): Nafcillin or Oxacillin 12 g/24h IV q4–6h for 6 weeks ± Gentamicin 3 mg/kg/24h IV/IM q8–12h for 3–5 days
Preferred regimen (2): Cefazolin 6 g/24h IV q8h for 6 weeks ± Gentamicin 3 mg/kg/24h IV/IM q8–12h for 3–5 days
Pediatric dose: Nafcillin or Oxacillin 200 mg/kg/24h IV q4–6h; Gentamicin 3 mg/kg/24h IV/IM q8h; Cefazolin 100 mg/kg/24h IV q8h; Gentamicin 3 mg/kg/24h IV/IM q8h

Native valve endocarditis caused by oxacillin-resistant staphylococci

Preferred regimen: Vancomycin 30 mg/kg/24h IV q12h for 6 weeks
Pediatric dose: Vancomycin 40 mg/kg/24h IV q8–12h

Prosthetic valve endocarditis caused by oxacillin-susceptible staphylococci

Preferred regimen: Nafcillin or Oxacillin 12 g/24h IV q4h for ≥ 6 weeks AND Rifampin 900 mg/24h IV/PO q8h for ≥ 6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8–12h for 2 weeks
Pediatric dose: Nafcillin or Oxacillin 200 mg/kg/24h IV q4–6h; Rifampin 20 mg/kg/24h IV/PO q8h; Gentamicin 3 mg/kg/24h IV/IM q8h

Prosthetic valve endocarditis caused by oxacillin-resistant staphylococci

Preferred regimen: Vancomycin 30 mg/kg 24 h q12h for ≥ 6 weeks AND Rifampin 900 mg/24h IV/PO q8h for ≥ 6 weeks AND Gentamicin 3 mg/kg/24h IV/IM q8–12h for 2 weeks
Pediatric dose: Vancomycin 40 mg/kg/24h IV q8–12h; Rifampin 20 mg/kg/24h IV/PO q8h (up to adult dose); Gentamicin 3 mg/kg/24h IV or IM q8h

Viridans group streptococci and Streptococcus bovis

Native valve endocarditis caused by highly penicillin-susceptible viridans group streptococci and Streptococcus bovis (MIC ≤ 0.12 μg/mL)

Preferred regimen: Penicillin G 12–18 million U/24h IV either continuously or q4–6h for 4 weeks OR Ceftriaxone 2 g/24h IV/IM in 1 dose for 4 weeks
Alternative regimen (1): (Penicillin G 12–18 million U/24h IV either continuously or q4h for 2 weeks OR Ceftriaxone 2 g/24h IV/IM in 1 dose for 2 weeks) AND Gentamicin 3 mg/kg/24h IV/IM in 1 dose for 2 weeks
Alternative regimen (2): Vancomycin 30 mg/kg/24h IV q12h not to exceed 2 g/24h for 4 weeks
Pediatric dose: Penicillin G 200,000 U/kg/24h IV q4–6h; Ceftriaxone 100 mg/kg/24h IV/IM in 1 dose; Gentamicin 3 mg/kg/24h IV/IM in 1 dose or q8h; Vancomycin 40 mg/kg/24h IV q8–12h

Native valve endocarditis caused by relatively penicillin-resistant viridans group streptococci and Streptococcus bovis (MIC > 0.12 to ≤ 0.5 μg/mL)

Preferred regimen (1): (Penicillin G 24 million U/24h IV either continuously or q4–6h for 4 weeks OR Ceftriaxone 2 g/24h IV/IM in 1 dose for 4 weeks) AND Gentamicin 3 mg/kg/24h IV/IM in 1 dose for 2 weeks
Preferred regimen (2): Vancomycin 30 mg/kg/24h IV q12h not to exceed 2 g/24h for 4 weeks
Pediatric dose: Penicillin G 200,000 U/kg/24h IV q4–6h; Ceftriaxone 100 mg/kg/24h IV/IM in 1 dose; Gentamicin 3 mg/kg/24h IV/IM in 1 dose or q8h; Vancomycin 40 mg/kg/24h IV q8–12h

Prosthetic valve endocarditis caused by highly penicillin-susceptible viridans group streptococci and Streptococcus bovis (MIC ≤ 0.12 μg/mL)

Preferred regimen (1): (Penicillin G 24 million U/24h IV either continuously or q4–6h for 6 weeks OR Ceftriaxone 2 g/24h IV/IM in 1 dose for 6 weeks) ± Gentamicin 3 mg/kg/24h IV/IM in 1 dose for 2 weeks
Preferred regimen (2): Vancomycin 30 mg/kg/24h IV q12h not to exceed 2 g/24h for 6 weeks
Pediatric dose: Penicillin G 200,000 U/kg/24h IV q4–6h; Ceftriaxone 100 mg/kg/24h IV/IM in 1 dose; Gentamicin 3 mg/kg/24h IV/IM in 1 dose or q8h; Vancomycin 40 mg/kg/24h IV q8–12h

Prosthetic valve endocarditis caused by relatively penicillin-resistant viridans group streptococci and Streptococcus bovis (MIC > 0.12 μg/mL)

Preferred regimen (1): (Penicillin G 24 million U/24h IV either continuously or q4–6h for 6 weeks OR Ceftriaxone 2 g/24h IV/IM in 1 dose for 6 weeks) AND Gentamicin 3 mg/kg/24h IV/IM in 1 dose for 2 weeks
Preferred regimen (2): Vancomycin 30 mg/kg/24h IV q12h not to exceed 2 g/24h for 6 weeks
Pediatric dose: Penicillin G 200,000 U/kg/24h IV q4–6h; Ceftriaxone 100 mg/kg/24h IV/IM in 1 dose; Gentamicin 3 mg/kg/24h IV/IM in 1 dose or q8h; Vancomycin 40 mg/kg/24h IV q8–12h

Intravascular catheter-related infections ⇧ Return to Top ⇧

Mediastinitis, acute ⇧ Return to Top ⇧

Mycotic aneurysm ⇧ Return to Top ⇧

Empiric antimicrobial therapy^[2]

Preferred regimen: Vancomycin 2 g/day IV divided q6-12h targeting trough concentration of 15-20 μg/mL for 6 weeks (for critically ill patient, start with a loading dose of 25 mg/kg followed by 15 mg/kg q12h) AND (Ceftriaxone 2 g IV q24h for 6 weeks OR Piperacillin-Tazobactam 3.375 g IV q6h for 6 weeks OR Ciprofloxacin 400 mg IV q12h for 6 weeks)
Alternative regimen: Consider substituting Daptomycin for Vancomycin. Consider Cefepime, Imipenem-Cilastatin, Meropenem, or Ertapenem for Gram-negative bacteria.

Myocarditis

Lyme carditis ⇧ Return to Top ⇧

Lyme carditis, adult^[3]

Parenteral regimen

Preferred regimen: Ceftriaxone 2 g IV q24h for 14 (14–21) days
Alternative regimen: Cefotaxime 2 g IV q8h for 14 (14–21) days OR Penicillin G 18–24 million U/day IV q4h for 14 (14–21) days

Oral regimen

Preferred regimen: Amoxicillin 500 mg tid for 14 (14–21) days OR Doxycycline 100 mg bid for 14 (14–21) days OR Cefuroxime 500 mg bid for 14 (14–21) days
Alternative regimen: Azithromycin 500 mg PO qd for 7–10 days OR Clarithromycin 500 mg PO bid for 14–21 days (if the patient is not pregnant) OR Erythromycin 500 mg PO qid for 14–21 days

Note (1): Parenteral regimen is recommended at the start of therapy for patients who have been hospitalized for cardiac monitoring; oral regimen may be substituted to complete a course of therapy or to treat ambulatory patients.

Note (2): A temporary pacemaker may be required for patients with advanced heart block.

Note (3): Patients treated with macrolides should be closely observed to ensure resolution of the clinical manifestations.

Lyme carditis, pediatric^[4]

Parenteral regimen

Preferred regimen: Ceftriaxone 50–75 mg/kg IV q24h (maximum, 2 g) for 14 (14–21) days
Alternative regimen: Cefotaxime 150–200 mg/kg/day IV q6–8h (maximum, 6 g per day) for 14 (14–21) days OR Penicillin G 200,000–400,000 U/kg/day IV q4h (not to exceed 18–24 million U per day) for 14 (14–21) days

Oral regimen

Preferred regimen: Amoxicillin 50 mg/kg/day PO tid (maximum, 500 mg per dose) for 14 (14–21) days OR Doxycycline (for children aged ≥ 􏱢8 years) 4 mg/kg/day PO bid (maximum, 100 mg per dose) for 14 (14–21) days OR Cefuroxime 30 mg/kg/day PO bid (maximum, 500 mg per dose) for 14 (14–21) days
Alternative regimen: Azithromycin 10 mg/kg/day (maximum of 500 mg per day) for 7–10 days OR Clarithromycin 7.5 mg/kg PO bid (maximum of 500 mg per dose) for 14–21 days OR Erythromycin 12.5 mg/kg PO qid (maximum of 500 mg per dose) for 14–21 days

Note (1): Parenteral regimen is recommended at the start of therapy for patients who have been hospitalized for cardiac monitoring; oral regimen may be substituted to complete a course of therapy or to treat ambulatory patients.

Note (2): A temporary pacemaker may be required for patients with advanced heart block.

Note (3): Patients treated with macrolides should be closely observed to ensure resolution of the clinical manifestations.

Myocarditis, viral ⇧ Return to Top ⇧

Pericarditis

Pericarditis, bacterial ⇧ Return to Top ⇧

Bacterial pericarditis

Empiric antimicrobial therapy^[5]^[6]

Preferred regimen: Vancomycin 1 g IV q12h targeting trough levels of 15–20 μg/mL for 28 days AND Ciprofloxacin 400 mg IV q12h for 28 days
Alternative regimen (1): Vancomycin 1 g IV q12h targeting trough levels of 15–20 μg/mL for 28 days AND Cefepime 2 g IV q12h for 28 days
Alternative regimen (2): Vancomycin 1 g IV q12h targeting trough levels of 15–20 μg/mL for 14–42 days AND Ceftriaxone 2 g IV q24h for 14–42 days

Note: Pericardiocentesis must be promptly performed. Pericardial drainage combined with effective systemic antibiotic therapy is mandatory (antistaphylococcal agent plus aminoglycoside, followed by tailored antibiotic therapy according to cultures). Frequent irrigation of the pericardial cavity with urokinase or streptokinase may be considered. Open surgical drainage through subxiphoid pericardiotomy is preferable. Pericardiectomy may be required in patients with dense adhesions, loculated and thick purulent effusion, recurrence of tamponade, persistent infection, and progression to constriction.

Specific considerations^[7]^[8]^[9]^[10]

Purulent pericarditis with contiguous pneumonia

Preferred regimen: Vancomycin 1 g IV q12h targeting trough levels of 15–20 μg/mL AND (Ceftriaxone 1–2 g IV q12h OR Cefotaxime 2 g IV q6–8h) AND (Ciprofloxacin 400 mg IV q12h OR Levofloxacin 500–750 mg IV q24h)

Purulent pericarditis with contiguous head and neck infection

Preferred regimen: Imipenem 500 mg IV q6–8h OR Ampicillin-Sulbactam 3 g IV q6h

Purulent pericarditis secondary to infective endocarditis

Preferred regimen: Vancomycin 15–20 mg/kg IV q8–12h targeting trough levels of 15–20 μg/mL AND Gentamicin 3 mg/kg/day IV q8–12h

Purulent pericarditis after cardiac surgery, pediatric

Preferred regimen: Vancomycin 15 mg/kg IV q6h targeting trough levels of 15–20 μg/mL AND (Ceftriaxone 100 mg/kg/day IV q12–24h OR Cefotaxime 200–300 mg/kg/day IV q6–8h) AND Gentamicin 6–7.5 mg/kg/day IV q8h

Purulent pericarditis with genitourinary infection, pediatric

Preferred regimen: Vancomycin 15 mg/kg IV q6h targeting trough levels of 15–20 μg/mL AND (Ceftriaxone 100 mg/kg/day IV q12–24h OR Cefotaxime 200–300 mg/kg/day IV q6–8h) AND Gentamicin 6–7.5 mg/kg/day IV q8h

Purulent pericarditis in immunocompromised host, pediatric

Preferred regimen: Vancomycin 15 mg/kg IV q6h targeting trough levels of 15–20 μg/mL AND (Ceftriaxone 100 mg/kg/day IV q12–24h OR Cefotaxime 200–300 mg/kg/day IV q6–8h) AND Gentamicin 6–7.5 mg/kg/day IV q8h

Pathogen-directed antimicrobial therapy^[11]

Anaerobes

Preferred regimen: Clindamycin 600–900 mg IV q8h for 14–42 days OR Metronidazole 7.5 mg/kg IV q6h for 14–42 days OR Ampicillin-Sulbactam 3 g IV q6h for 14–42 days

Gram-negative bacilli

Preferred regimen: Ciprofloxacin 400 mg IV q12h for 14–42 days OR Levofloxacin 500–750 mg IV q24h for 14–42 days OR Cefepime 2 g IV q12h for 14–42 days

Legionella pneumophila

Preferred regimen: Ciprofloxacin 400 mg IV q12h for 14–42 days OR Levofloxacin 500–750 mg IV q24h for 14–42 days OR Azithromycin 500 mg IV q24h for 14–42 days

Mycoplasma pneumoniae

Preferred regimen: Doxycycline 100 mg IV q12h for 14–42 days OR Azithromycin 500 mg IV q24h for 14–42 days

Neisseria meningitidis

Preferred regimen: Penicillin G 5–24 MU/day IM/IV q4–6h for 14–42 days OR Cefotaxime 2 g IV q6–8h for 14–42 days OR Ceftriaxone 2 g IV q24h for 14–42 days

Staphylococcus aureus, methicillin-susceptible

Preferred regimen: Nafcillin 1–2 g IV q4h for 14–42 days OR Oxacillin 1–2 g IV q4h for 14–42 days OR Cefazolin 1–2 g IV q48h for 14–42 days OR Vancomycin 1 g IV q12h targeting trough levels of 15–20 μg/mL for 14–42 days OR Clindamycin 600–900 mg IV q8h for 14–42 days

Staphylococcus aureus, methicillin-resistant

Preferred regimen: Vancomycin 1 g IV q12h targeting trough levels of 15–20 μg/mL for 14–42 days OR Linezolid 600 mg IV q12h for 14–42 days

Streptococcus pneumoniae, penicillin-susceptible

Preferred regimen: Penicillin G 5–24 MU/day IM/IV q4–6h for 14–42 days OR Cefotaxime 2 g IV q6–8h for 14–42 days OR Ciprofloxacin 400 mg IV q12h for 14–42 days OR Levofloxacin 500–750 mg IV q24h for 14–42 days

Streptococcus pneumoniae, penicillin-resistant

Preferred regimen: Ciprofloxacin 400 mg IV q12h for 14–42 days OR Levofloxacin 500–750 mg IV q24h for 14–42 days OR Vancomycin 1 g IV q12h targeting trough levels of 15–20 μg/mL for 14–42 days

Pericarditis, fungal ⇧ Return to Top ⇧

Pericarditis, tuberculous ⇧ Return to Top ⇧

Pericarditis, viral ⇧ Return to Top ⇧

Rheumatic fever

Rheumatic fever, primary prophylaxis ⇧ Return to Top ⇧

Rheumatic fever, secondary prophylaxis ⇧ Return to Top ⇧

Septic pelvic vein thrombophlebitis ⇧ Return to Top ⇧

Central Nervous System

Brain abscess ⇧ Return to Top ⇧

Cerebrospinal fluid shunt infection ⇧ Return to Top ⇧

Encephalitis ⇧ Return to Top ⇧

Epidural abscess ⇧ Return to Top ⇧

Lyme neuroborreliosis ⇧ Return to Top ⇧

Meningitis, bacterial ⇧ Return to Top ⇧

Meningitis, MRSA ⇧ Return to Top ⇧

Meningitis, tuberculous ⇧ Return to Top ⇧

Septic thrombosis of cavernous or dural venous sinus ⇧ Return to Top ⇧

Septic thrombosis of cavernous or dural venous sinus, MRSA ⇧ Return to Top ⇧

Subdural empyema ⇧ Return to Top ⇧

Head and Neck

Anthrax, oropharyngeal ⇧ Return to Top ⇧

Buccal cellulitis ⇧ Return to Top ⇧

Cervico-facial actinomycosis ⇧ Return to Top ⇧

Deep neck infection ⇧ Return to Top ⇧

Facial cellulitis ⇧ Return to Top ⇧

Mastoiditis ⇧ Return to Top ⇧

Mastoiditis, Acute ⇧ Return to Top ⇧

Mastoiditis, Chronic ⇧ Return to Top ⇧

Odontogenic infection ⇧ Return to Top ⇧

Orbital cellulitis ⇧ Return to Top ⇧

Oropharyngeal candidiasis ⇧ Return to Top ⇧

Otitis externa ⇧ Return to Top ⇧

Otitis externa, Chronic ⇧ Return to Top ⇧

Otitis externa, Fungal ⇧ Return to Top ⇧

Otitis externa, Malignant ⇧ Return to Top ⇧

Otitis externa, Swimmer's ear ⇧ Return to Top ⇧

Otitis media ⇧ Return to Top ⇧

Otitis media, Acute ⇧ Return to Top ⇧

Otitis media, Post-intubation ⇧ Return to Top ⇧

Otitis media, Prophylaxis ⇧ Return to Top ⇧

Otitis media, Treatment failure ⇧ Return to Top ⇧

Parotitis ⇧ Return to Top ⇧

Eye

Conjunctivitis ⇧ Return to Top ⇧

Blepharitis ⇧ Return to Top ⇧

Endophthalmitis, bacterial ⇧ Return to Top ⇧

Endophthalmitis, bleb-related ⇧ Return to Top ⇧

Endophthalmitis, candidal ⇧ Return to Top ⇧

Endophthalmitis, chronic ⇧ Return to Top ⇧

Endophthalmitis, mold ⇧ Return to Top ⇧

Endophthalmitis, post-cataract surgery, acute ⇧ Return to Top ⇧

Endophthalmitis, post-cataract surgery, chronic ⇧ Return to Top ⇧

Endophthalmitis, post-tramatic ⇧ Return to Top ⇧

Keratitis, bacterial ⇧ Return to Top ⇧

Keratitis, fungal ⇧ Return to Top ⇧

Keratitis, protozoal ⇧ Return to Top ⇧

Keratitis, viral ⇧ Return to Top ⇧

Ocular syphilis ⇧ Return to Top ⇧

Ocular toxocariasis ⇧ Return to Top ⇧

Ocular toxoplasmosis ⇧ Return to Top ⇧

Ocular tuberculosis ⇧ Return to Top ⇧

Orbital cellulitis ⇧ Return to Top ⇧

Periocular Infection ⇧ Return to Top ⇧

Retinal necrosis, acute, CMV ⇧ Return to Top ⇧

Retinal necrosis, acute, HSV or VZV ⇧ Return to Top ⇧

Retinal necrosis, progressive outer, VZV ⇧ Return to Top ⇧

Retinitis, CMV ⇧ Return to Top ⇧

Stye ⇧ Return to Top ⇧

Uveitis, acute anterior ⇧ Return to Top ⇧

Uveitis, Lyme disease ⇧ Return to Top ⇧

Upper Respiratory Tract

Epiglottitis ⇧ Return to Top ⇧

Jugular vein phlebitis ⇧ Return to Top ⇧

Laryngitis ⇧ Return to Top ⇧

Lemierre's syndrome ⇧ Return to Top ⇧

Ludwig's angina ⇧ Return to Top ⇧

Parapharyngeal space infection ⇧ Return to Top ⇧

Pharyngitis, diphtheria ⇧ Return to Top ⇧

Pharyngitis, streptococcal ⇧ Return to Top ⇧

Sinusitis, Acute ⇧ Return to Top ⇧

Sinusitis, Chronic ⇧ Return to Top ⇧

Sinusitis, Post-intubation ⇧ Return to Top ⇧

Sinusitis, Treatment failure ⇧ Return to Top ⇧

Stomatitis ⇧ Return to Top ⇧

Stomatitis, aphthous ⇧ Return to Top ⇧

Stomatitis, herpetic ⇧ Return to Top ⇧

Submandibular space infection ⇧ Return to Top ⇧

Tonsillitis ⇧ Return to Top ⇧

Ulcerative gingivitis ⇧ Return to Top ⇧

Vincent's angina ⇧ Return to Top ⇧

Lower Respiratory Tract

Acute bacterial exacerbations of chronic bronchitis ⇧ Return to Top ⇧

Bronchiectasis ⇧ Return to Top ⇧

Bronchiolitis ⇧ Return to Top ⇧

Bronchitis ⇧ Return to Top ⇧

Cystic fibrosis ⇧ Return to Top ⇧

Empyema ⇧ Return to Top ⇧

Influenza ⇧ Return to Top ⇧

Inhalational anthrax, Prophylaxis ⇧ Return to Top ⇧

Inhalational anthrax, Treatment ⇧ Return to Top ⇧

Pertussis ⇧ Return to Top ⇧

Pneumonia, Acinetobacter ⇧ Return to Top ⇧

Pneumonia, Actinomycosis ⇧ Return to Top ⇧

Pneumonia, Anaerobes ⇧ Return to Top ⇧

Pneumonia, Aspiration pneumonia ⇧ Return to Top ⇧

Pneumonia, Chlamydophila ⇧ Return to Top ⇧

Pneumonia, community-acquired ⇧ Return to Top ⇧

Pneumonia, concomitant influenza ⇧ Return to Top ⇧

Pneumonia, Cytomegalovirus ⇧ Return to Top ⇧

Pneumonia, Haemophilus Influenza ⇧ Return to Top ⇧

Pneumonia, health care-associated ⇧ Return to Top ⇧

Pneumonia, hospital-acquired ⇧ Return to Top ⇧

Pneumonia, Klebsiella ⇧ Return to Top ⇧

Pneumonia, Legionella ⇧ Return to Top ⇧

Pneumonia, Lung abscess ⇧ Return to Top ⇧

Pneumonia, Meliodosis ⇧ Return to Top ⇧

Pneumonia, Moraxella catarrhalis ⇧ Return to Top ⇧

Pneumonia, Mycoplasma ⇧ Return to Top ⇧

Pneumonia, neutropenic patient ⇧ Return to Top ⇧

Pneumonia, Nocardia ⇧ Return to Top ⇧

Pneumonia, post-influenza ⇧ Return to Top ⇧

Pneumonia, Pseuodomonas ⇧ Return to Top ⇧

Pneumonia, Staphylococcus aureus ⇧ Return to Top ⇧

Pneumonia, Stenotrophomonas ⇧ Return to Top ⇧

Pneumonia, Streptococcus pneumoniae ⇧ Return to Top ⇧

Pneumonia, Tularemia ⇧ Return to Top ⇧

Pneumonia, Yersinia pestis ⇧ Return to Top ⇧

Gastrointestinal and Intraabdominal

Anthrax, gastrointestinal ⇧ Return to Top ⇧

Appendicitis ⇧ Return to Top ⇧

Biliary sepsis ⇧ Return to Top ⇧

Cholangitis ⇧ Return to Top ⇧

Cholecystitis ⇧ Return to Top ⇧

Diverticulitis ⇧ Return to Top ⇧

Esophagitis ⇧ Return to Top ⇧

Hepatic abscess ⇧ Return to Top ⇧

Hepatitis A ⇧ Return to Top ⇧

Hepatitis B ⇧ Return to Top ⇧

Hepatitis C ⇧ Return to Top ⇧

Hepatitis D ⇧ Return to Top ⇧

Hepatitis E ⇧ Return to Top ⇧

Infectious diarrhea ⇧ Return to Top ⇧

Leptospirosis ⇧ Return to Top ⇧

Pancreatitis ⇧ Return to Top ⇧

Peliosis hepatitis ⇧ Return to Top ⇧

Peptic ulcer disease ⇧ Return to Top ⇧

Peritonitis, secondary to bowel perforation ⇧ Return to Top ⇧

Peritonitis, secondary to dialysis ⇧ Return to Top ⇧

Peritonitis, secondary to ruptured appendix ⇧ Return to Top ⇧

Peritonitis, secondary to ruptured diverticula ⇧ Return to Top ⇧

Peritonitis, spontaneous bacterial ⇧ Return to Top ⇧

Post-transplant infected biloma ⇧ Return to Top ⇧

Splenic abscess ⇧ Return to Top ⇧

Tropical sprue ⇧ Return to Top ⇧

Typhlitis ⇧ Return to Top ⇧

Variceal bleeding, prophylaxis ⇧ Return to Top ⇧

Whipple's disease ⇧ Return to Top ⇧

Genitourinary

Asymptomatic bacteriuria ⇧ Return to Top ⇧

Bacterial vaginosis ⇧ Return to Top ⇧

Cervicitis ⇧ Return to Top ⇧

Chancroid ⇧ Return to Top ⇧

Chlamydial infections ⇧ Return to Top ⇧

Chorioamnionitis ⇧ Return to Top ⇧

Cystitis ⇧ Return to Top ⇧

Ectoparasitic infections ⇧ Return to Top ⇧

Epididymitis ⇧ Return to Top ⇧

Genital herpes ⇧ Return to Top ⇧

Gonococcal infections ⇧ Return to Top ⇧

Granuloma Inguinale ⇧ Return to Top ⇧

Human papillomavirus infection ⇧ Return to Top ⇧

Lymphogranuloma venereum ⇧ Return to Top ⇧

Pelvic inflammatory disease ⇧ Return to Top ⇧

Proctocolitis ⇧ Return to Top ⇧

Prostatitis, acute bacterial ⇧ Return to Top ⇧

Prostatitis, chronic bacterial ⇧ Return to Top ⇧

Pyelonephritis ⇧ Return to Top ⇧

Syphilis ⇧ Return to Top ⇧

Urethritis ⇧ Return to Top ⇧

Vulvovaginal candidiasis ⇧ Return to Top ⇧

Musculoskeletal

Bursitis ⇧ Return to Top ⇧

Osteomyelitis, candidal ⇧ Return to Top ⇧

Osteomyelitis, chronic ⇧ Return to Top ⇧

Osteomyelitis, contiguous with vascular insufficiency ⇧ Return to Top ⇧

Osteomyelitis, contiguous without vascular insufficiency ⇧ Return to Top ⇧

Osteomyelitis, diabetic foot ⇧ Return to Top ⇧

Osteomyelitis, foot bone ⇧ Return to Top ⇧

Osteomyelitis, foot puncture wound ⇧ Return to Top ⇧

Osteomyelitis, hematogenous ⇧ Return to Top ⇧

Osteomyelitis, hemoglobinopathy ⇧ Return to Top ⇧

Osteomyelitis, prosthetic joint infection ⇧ Return to Top ⇧

Osteomyelitis, spinal implant ⇧ Return to Top ⇧

Osteomyelitis, sternal ⇧ Return to Top ⇧

Reactive arthritis, post-streptococcal arthritis ⇧ Return to Top ⇧

Reactive arthritis, Reiter's syndrome ⇧ Return to Top ⇧

Septic arthritis, brucellosis ⇧ Return to Top ⇧

Septic arthritis, candidal ⇧ Return to Top ⇧

Septic arthritis, gonococcal ⇧ Return to Top ⇧

Septic arthritis, Gram-negative bacilli ⇧ Return to Top ⇧

Septic arthritis, Histoplasmosis ⇧ Return to Top ⇧

Septic arthritis, Lyme disease ⇧ Return to Top ⇧

Septic arthritis, Mycobacterium tuberculosis ⇧ Return to Top ⇧

Septic arthritis, pneumococcal ⇧ Return to Top ⇧

Septic arthritis, post-intraarticular injection ⇧ Return to Top ⇧

Septic arthritis, staphylococcal ⇧ Return to Top ⇧

Septic arthritis, streptococcal ⇧ Return to Top ⇧

Skin and Soft Tissues

Acne vulgaris ⇧ Return to Top ⇧

Acne rosacea ⇧ Return to Top ⇧

Anthrax, cutaneous ⇧ Return to Top ⇧

Bacillary angiomatosis ⇧ Return to Top ⇧

Bite wounds ⇧ Return to Top ⇧

Bubonic plague ⇧ Return to Top ⇧

Carbuncle ⇧ Return to Top ⇧

Cat scratch disease ⇧ Return to Top ⇧

Cellulitis ⇧ Return to Top ⇧

Ecthyma ⇧ Return to Top ⇧

Erysipelas ⇧ Return to Top ⇧

Erysipeloid ⇧ Return to Top ⇧

Erythrasma ⇧ Return to Top ⇧

Fournier gangrene ⇧ Return to Top ⇧

Furuncle ⇧ Return to Top ⇧

Gas gangrene ⇧ Return to Top ⇧

Glanders ⇧ Return to Top ⇧

Impetigo ⇧ Return to Top ⇧

Lyme disease, cutaneous ⇧ Return to Top ⇧

Mastitis ⇧ Return to Top ⇧

Necrotizing fasciitis ⇧ Return to Top ⇧

Pilonidal cyst ⇧ Return to Top ⇧

Pyomyositis ⇧ Return to Top ⇧

Seborrheic dermatitis ⇧ Return to Top ⇧

Skin and soft tissue infection in neutropenic fever ⇧ Return to Top ⇧

Skin and soft tissue infection in cellular immunodeficiency ⇧ Return to Top ⇧

Surgical site infection ⇧ Return to Top ⇧

Tularemia ⇧ Return to Top ⇧

Vascular insufficieny ulcer ⇧ Return to Top ⇧

Vibrio infection ⇧ Return to Top ⇧

Wound infection ⇧ Return to Top ⇧

Yaws ⇧ Return to Top ⇧

Systemic

Anaplasmosis ⇧ Return to Top ⇧

Babesiosis ⇧ Return to Top ⇧

Bartonella ⇧ Return to Top ⇧

Botulism ⇧ Return to Top ⇧

Boutonneuese fever ⇧ Return to Top ⇧

Brucellosis ⇧ Return to Top ⇧

Diptheria ⇧ Return to Top ⇧

Ehrlichiolsis ⇧ Return to Top ⇧

Febrile neutropenia, prophylaxis ⇧ Return to Top ⇧

Febrile neutropenia, treatment ⇧ Return to Top ⇧

Kawasaki syndrome ⇧ Return to Top ⇧

Leptospirosis ⇧ Return to Top ⇧

Lymphadenitis ⇧ Return to Top ⇧

Lymphangitis ⇧ Return to Top ⇧

Relapsing fever ⇧ Return to Top ⇧

Rocky Mountain spotted fever ⇧ Return to Top ⇧

Salmonella bacteremia ⇧ Return to Top ⇧

Sepsis ⇧ Return to Top ⇧

Staphylococcal toxic shock syndrome ⇧ Return to Top ⇧

Streptococcal toxic shock syndrome ⇧ Return to Top ⇧

Tetanus ⇧ Return to Top ⇧

Tularemia ⇧ Return to Top ⇧

Typhoid fever ⇧ Return to Top ⇧

Typhus, louse-borne ⇧ Return to Top ⇧

Typhus, murine ⇧ Return to Top ⇧

Typhus, scrub ⇧ Return to Top ⇧

↑ Baddour, Larry M.; Wilson, Walter R.; Bayer, Arnold S.; Fowler, Vance G.; Bolger, Ann F.; Levison, Matthew E.; Ferrieri, Patricia; Gerber, Michael A.; Tani, Lloyd Y.; Gewitz, Michael H.; Tong, David C.; Steckelberg, James M.; Baltimore, Robert S.; Shulman, Stanford T.; Burns, Jane C.; Falace, Donald A.; Newburger, Jane W.; Pallasch, Thomas J.; Takahashi, Masato; Taubert, Kathryn A.; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America (2005-06-14). "Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): –394-434. doi:10.1161/CIRCULATIONAHA.105.165564. ISSN 1524-4539. PMID 15956145.
↑ Gilbert, David (2014). The Sanford guide to antimicrobial therapy 2014. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808782.
↑ Wormser, Gary P.; Dattwyler, Raymond J.; Shapiro, Eugene D.; Halperin, John J.; Steere, Allen C.; Klempner, Mark S.; Krause, Peter J.; Bakken, Johan S.; Strle, Franc; Stanek, Gerold; Bockenstedt, Linda; Fish, Durland; Dumler, J. Stephen; Nadelman, Robert B. (2006-11-01). "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 43 (9): 1089–1134. doi:10.1086/508667. ISSN 1537-6591. PMID 17029130.
↑ Wormser, Gary P.; Dattwyler, Raymond J.; Shapiro, Eugene D.; Halperin, John J.; Steere, Allen C.; Klempner, Mark S.; Krause, Peter J.; Bakken, Johan S.; Strle, Franc; Stanek, Gerold; Bockenstedt, Linda; Fish, Durland; Dumler, J. Stephen; Nadelman, Robert B. (2006-11-01). "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 43 (9): 1089–1134. doi:10.1086/508667. ISSN 1537-6591. PMID 17029130.
↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.
↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.
↑ Maisch, Bernhard; Seferović, Petar M.; Ristić, Arsen D.; Erbel, Raimund; Rienmüller, Reiner; Adler, Yehuda; Tomkowski, Witold Z.; Thiene, Gaetano; Yacoub, Magdi H.; Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology (2004-04). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology". European Heart Journal. 25 (7): 587–610. doi:10.1016/j.ehj.2004.02.002. ISSN 0195-668X. PMID 15120056. Check date values in: |date= (help)
↑ Pankuweit, Sabine; Ristić, Arsen D.; Seferović, Petar M.; Maisch, Bernhard (2005). "Bacterial pericarditis: diagnosis and management". American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions. 5 (2): 103–112. ISSN 1175-3277. PMID 15725041.
↑ Goodman, null (2000-08). "Purulent Pericarditis". Current Treatment Options in Cardiovascular Medicine. 2 (4): 343–350. ISSN 1092-8464. PMID 11096539. Check date values in: |date= (help)
↑ Cherry, James (2014). Feigin and Cherry's textbook of pediatric infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455711772.
↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.

[1] Baddour, Larry M.; Wilson, Walter R.; Bayer, Arnold S.; Fowler, Vance G.; Bolger, Ann F.; Levison, Matthew E.; Ferrieri, Patricia; Gerber, Michael A.; Tani, Lloyd Y.; Gewitz, Michael H.; Tong, David C.; Steckelberg, James M.; Baltimore, Robert S.; Shulman, Stanford T.; Burns, Jane C.; Falace, Donald A.; Newburger, Jane W.; Pallasch, Thomas J.; Takahashi, Masato; Taubert, Kathryn A.; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America (2005-06-14). "Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): –394-434. doi:10.1161/CIRCULATIONAHA.105.165564. ISSN 1524-4539. PMID 15956145.

[2] Gilbert, David (2014). The Sanford guide to antimicrobial therapy 2014. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808782.

[3] Wormser, Gary P.; Dattwyler, Raymond J.; Shapiro, Eugene D.; Halperin, John J.; Steere, Allen C.; Klempner, Mark S.; Krause, Peter J.; Bakken, Johan S.; Strle, Franc; Stanek, Gerold; Bockenstedt, Linda; Fish, Durland; Dumler, J. Stephen; Nadelman, Robert B. (2006-11-01). "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 43 (9): 1089–1134. doi:10.1086/508667. ISSN 1537-6591. PMID 17029130.

[4] Wormser, Gary P.; Dattwyler, Raymond J.; Shapiro, Eugene D.; Halperin, John J.; Steere, Allen C.; Klempner, Mark S.; Krause, Peter J.; Bakken, Johan S.; Strle, Franc; Stanek, Gerold; Bockenstedt, Linda; Fish, Durland; Dumler, J. Stephen; Nadelman, Robert B. (2006-11-01). "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 43 (9): 1089–1134. doi:10.1086/508667. ISSN 1537-6591. PMID 17029130.

[5] Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.

[6] Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.

[7] Maisch, Bernhard; Seferović, Petar M.; Ristić, Arsen D.; Erbel, Raimund; Rienmüller, Reiner; Adler, Yehuda; Tomkowski, Witold Z.; Thiene, Gaetano; Yacoub, Magdi H.; Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology (2004-04). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology". European Heart Journal. 25 (7): 587–610. doi:10.1016/j.ehj.2004.02.002. ISSN 0195-668X. PMID 15120056. Check date values in: |date= (help)

[8] Pankuweit, Sabine; Ristić, Arsen D.; Seferović, Petar M.; Maisch, Bernhard (2005). "Bacterial pericarditis: diagnosis and management". American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions. 5 (2): 103–112. ISSN 1175-3277. PMID 15725041.

[9] Goodman, null (2000-08). "Purulent Pericarditis". Current Treatment Options in Cardiovascular Medicine. 2 (4): 343–350. ISSN 1092-8464. PMID 11096539. Check date values in: |date= (help)

[10] Cherry, James (2014). Feigin and Cherry's textbook of pediatric infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455711772.

[11] Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

@@ Line 1: / Line 1: @@
-<h2>Cardiovascular</h2>
+<h3>Cardiovascular</h3>
-<h4>Aortitis, infectious {{ID-returntotop-organ}}</h4>
+<h5>Aortitis, infectious {{ID-returntotop-organ}}</h5>
-<h4>Cardiovascular implantable electronic device infections {{ID-returntotop-organ}}</h4>
+<h5>Cardiovascular implantable electronic device infections {{ID-returntotop-organ}}</h5>
-<h3>Endocarditis</h3>
+<h4>Endocarditis</h4>
-<h4>Endocarditis, prophylaxis {{ID-returntotop-organ}}</h4>
+<h5>Endocarditis, prophylaxis {{ID-returntotop-organ}}</h5>
-<h4>Endocarditis, treatment {{ID-returntotop-organ}}</h4>
+<h5>Endocarditis, treatment {{ID-returntotop-organ}}</h5>
 * Infective endocarditis<ref>{{Cite journal| doi = 10.1161/CIRCULATIONAHA.105.165564| issn = 1524-4539| volume = 111| issue = 23| pages = –394-434| last1 = Baddour| first1 = Larry M.| last2 = Wilson| first2 = Walter R.| last3 = Bayer| first3 = Arnold S.| last4 = Fowler| first4 = Vance G.| last5 = Bolger| first5 = Ann F.| last6 = Levison| first6 = Matthew E.| last7 = Ferrieri| first7 = Patricia| last8 = Gerber| first8 = Michael A.| last9 = Tani| first9 = Lloyd Y.| last10 = Gewitz| first10 = Michael H.| last11 = Tong| first11 = David C.| last12 = Steckelberg| first12 = James M.| last13 = Baltimore| first13 = Robert S.| last14 = Shulman| first14 = Stanford T.| last15 = Burns| first15 = Jane C.| last16 = Falace| first16 = Donald A.| last17 = Newburger| first17 = Jane W.| last18 = Pallasch| first18 = Thomas J.| last19 = Takahashi| first19 = Masato| last20 = Taubert| first20 = Kathryn A.| last21 = Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease| last22 = Council on Cardiovascular Disease in the Young| last23 = Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia| last24 = American Heart Association| last25 = Infectious Diseases Society of America| title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America| journal = Circulation| date = 2005-06-14| pmid = 15956145}}</ref>
@@ Line 114: / Line 114: @@
 ::::* Pediatric dose: [[Penicillin G]] 200,000 U/kg/24h IV q4–6h; [[Ceftriaxone]] 100 mg/kg/24h IV/IM in 1 dose; [[Gentamicin]] 3 mg/kg/24h IV/IM in 1 dose or q8h; [[Vancomycin]] 40 mg/kg/24h IV q8–12h
-<h4>Intravascular catheter-related infections {{ID-returntotop-organ}}</h4>
+<h5>Intravascular catheter-related infections {{ID-returntotop-organ}}</h5>
-<h4>Mediastinitis, acute {{ID-returntotop-organ}}</h4>
+<h5>Mediastinitis, acute {{ID-returntotop-organ}}</h5>
-<h3>Mycotic aneurysm {{ID-returntotop-organ}}</h3>
+<h4>Mycotic aneurysm {{ID-returntotop-organ}}</h4>
 * '''Empiric antimicrobial therapy'''<ref>{{cite book | last = Gilbert | first = David | title = The Sanford guide to antimicrobial therapy 2014 | publisher = Antimicrobial Therapy | location = Sperryville, Va | year = 2014 | isbn = 978-1930808782 }}</ref>
@@ Line 124: / Line 124: @@
 :* Alternative regimen: Consider substituting [[Daptomycin]] for Vancomycin.  Consider [[Cefepime]], [[Imipenem-Cilastatin]], [[Meropenem]], or [[Ertapenem]] for Gram-negative bacteria.
-<h3>Myocarditis</h3>
+<h4>Myocarditis</h4>
-<h4>Lyme carditis {{ID-returntotop-organ}}</h4>
+<h5>Lyme carditis {{ID-returntotop-organ}}</h5>
 * '''Lyme carditis, adult'''<ref>{{Cite journal| doi = 10.1086/508667| issn = 1537-6591| volume = 43| issue = 9| pages = 1089–1134| last1 = Wormser| first1 = Gary P.| last2 = Dattwyler| first2 = Raymond J.| last3 = Shapiro| first3 = Eugene D.| last4 = Halperin| first4 = John J.| last5 = Steere| first5 = Allen C.| last6 = Klempner| first6 = Mark S.| last7 = Krause| first7 = Peter J.| last8 = Bakken| first8 = Johan S.| last9 = Strle| first9 = Franc| last10 = Stanek| first10 = Gerold| last11 = Bockenstedt| first11 = Linda| last12 = Fish| first12 = Durland| last13 = Dumler| first13 = J. Stephen| last14 = Nadelman| first14 = Robert B.| title = The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America| journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America| date = 2006-11-01| pmid = 17029130}}</ref>
@@ Line 150: / Line 150: @@
 ::: Note (3): Patients treated with macrolides should be closely observed to ensure resolution of the clinical manifestations.
-<h4>Myocarditis, viral {{ID-returntotop-organ}}</h4>
+<h5>Myocarditis, viral {{ID-returntotop-organ}}</h5>
-<h3>Pericarditis</h3>
+<h4>Pericarditis</h4>
-<h4>Pericarditis, bacterial {{ID-returntotop-organ}}</h4>
+<h5>Pericarditis, bacterial {{ID-returntotop-organ}}</h5>
 * Bacterial pericarditis
@@ Line 210: / Line 210: @@
 :::* Preferred regimen: [[Ciprofloxacin]] 400 mg IV q12h for 14–42 days {{or}} [[Levofloxacin]] 500–750 mg IV q24h for 14–42 days {{or}} [[Vancomycin]] 1 g IV q12h targeting trough levels of 15–20 μg/mL for 14–42 days
-<h4>Pericarditis, fungal {{ID-returntotop-organ}}</h4>
+<h5>Pericarditis, fungal {{ID-returntotop-organ}}</h5>
-<h4>Pericarditis, tuberculous {{ID-returntotop-organ}}</h4>
+<h5>Pericarditis, tuberculous {{ID-returntotop-organ}}</h5>
-<h4>Pericarditis, viral {{ID-returntotop-organ}}</h4>
+<h5>Pericarditis, viral {{ID-returntotop-organ}}</h5>
-<h3>Rheumatic fever</h3>
+<h4>Rheumatic fever</h4>
-<h4>Rheumatic fever, primary prophylaxis {{ID-returntotop-organ}}</h4>
+<h5>Rheumatic fever, primary prophylaxis {{ID-returntotop-organ}}</h5>
-<h4>Rheumatic fever, secondary prophylaxis {{ID-returntotop-organ}}</h4>
+<h5>Rheumatic fever, secondary prophylaxis {{ID-returntotop-organ}}</h5>
-<h4>Septic pelvic vein thrombophlebitis {{ID-returntotop-organ}}</h4>
+<h5>Septic pelvic vein thrombophlebitis {{ID-returntotop-organ}}</h5>
-<h2>Central Nervous System</h2>
+<h3>Central Nervous System</h3>
-<h4>Brain abscess {{ID-returntotop-organ}}</h4>
+<h5>Brain abscess {{ID-returntotop-organ}}</h5>
-<h4>Cerebrospinal fluid shunt infection {{ID-returntotop-organ}}</h4>
+<h5>Cerebrospinal fluid shunt infection {{ID-returntotop-organ}}</h5>
-<h4>Encephalitis {{ID-returntotop-organ}}</h4>
+<h5>Encephalitis {{ID-returntotop-organ}}</h5>
-<h4>Epidural abscess {{ID-returntotop-organ}}</h4>
+<h5>Epidural abscess {{ID-returntotop-organ}}</h5>
-<h4>Lyme neuroborreliosis {{ID-returntotop-organ}}</h4>
+<h5>Lyme neuroborreliosis {{ID-returntotop-organ}}</h5>
-<h4>Meningitis, bacterial {{ID-returntotop-organ}}</h4>
+<h5>Meningitis, bacterial {{ID-returntotop-organ}}</h5>
-<h4>Meningitis, MRSA {{ID-returntotop-organ}}</h4>
+<h5>Meningitis, MRSA {{ID-returntotop-organ}}</h5>
-<h4>Meningitis, tuberculous {{ID-returntotop-organ}}</h4>
+<h5>Meningitis, tuberculous {{ID-returntotop-organ}}</h5>
-<h4>Septic thrombosis of cavernous or dural venous sinus {{ID-returntotop-organ}}</h4>
+<h5>Septic thrombosis of cavernous or dural venous sinus {{ID-returntotop-organ}}</h5>
-<h4>Septic thrombosis of cavernous or dural venous sinus, MRSA {{ID-returntotop-organ}}</h4>
+<h5>Septic thrombosis of cavernous or dural venous sinus, MRSA {{ID-returntotop-organ}}</h5>
-<h4>Subdural empyema {{ID-returntotop-organ}}</h4>
+<h5>Subdural empyema {{ID-returntotop-organ}}</h5>
-<h2>Head and Neck</h2>
+<h3>Head and Neck</h3>
-<h4>Anthrax, oropharyngeal {{ID-returntotop-organ}}</h4>
+<h5>Anthrax, oropharyngeal {{ID-returntotop-organ}}</h5>
-<h4>Buccal cellulitis {{ID-returntotop-organ}}</h4>
+<h5>Buccal cellulitis {{ID-returntotop-organ}}</h5>
-<h4>Cervico-facial actinomycosis {{ID-returntotop-organ}}</h4>
+<h5>Cervico-facial actinomycosis {{ID-returntotop-organ}}</h5>
-<h4>Deep neck infection {{ID-returntotop-organ}}</h4>
+<h5>Deep neck infection {{ID-returntotop-organ}}</h5>
-<h4>Facial cellulitis {{ID-returntotop-organ}}</h4>
+<h5>Facial cellulitis {{ID-returntotop-organ}}</h5>
-<h4>Mastoiditis {{ID-returntotop-organ}}</h4>
+<h5>Mastoiditis {{ID-returntotop-organ}}</h5>
-<h4>Mastoiditis, Acute {{ID-returntotop-organ}}</h4>
+<h5>Mastoiditis, Acute {{ID-returntotop-organ}}</h5>
-<h4>Mastoiditis, Chronic {{ID-returntotop-organ}}</h4>
+<h5>Mastoiditis, Chronic {{ID-returntotop-organ}}</h5>
-<h4>Odontogenic infection {{ID-returntotop-organ}}</h4>
+<h5>Odontogenic infection {{ID-returntotop-organ}}</h5>
-<h4>Orbital cellulitis {{ID-returntotop-organ}}</h4>
+<h5>Orbital cellulitis {{ID-returntotop-organ}}</h5>
-<h4>Oropharyngeal candidiasis {{ID-returntotop-organ}}</h4>
+<h5>Oropharyngeal candidiasis {{ID-returntotop-organ}}</h5>
-<h4>Otitis externa {{ID-returntotop-organ}}</h4>
+<h5>Otitis externa {{ID-returntotop-organ}}</h5>
-<h4>Otitis externa, Chronic {{ID-returntotop-organ}}</h4>
+<h5>Otitis externa, Chronic {{ID-returntotop-organ}}</h5>
-<h4>Otitis externa, Fungal {{ID-returntotop-organ}}</h4>
+<h5>Otitis externa, Fungal {{ID-returntotop-organ}}</h5>
-<h4>Otitis externa, Malignant {{ID-returntotop-organ}}</h4>
+<h5>Otitis externa, Malignant {{ID-returntotop-organ}}</h5>
-<h4>Otitis externa, Swimmer's ear {{ID-returntotop-organ}}</h4>
+<h5>Otitis externa, Swimmer's ear {{ID-returntotop-organ}}</h5>
-<h4>Otitis media {{ID-returntotop-organ}}</h4>
+<h5>Otitis media {{ID-returntotop-organ}}</h5>
-<h4>Otitis media, Acute {{ID-returntotop-organ}}</h4>
+<h5>Otitis media, Acute {{ID-returntotop-organ}}</h5>
-<h4>Otitis media, Post-intubation {{ID-returntotop-organ}}</h4>
+<h5>Otitis media, Post-intubation {{ID-returntotop-organ}}</h5>
-<h4>Otitis media, Prophylaxis {{ID-returntotop-organ}}</h4>
+<h5>Otitis media, Prophylaxis {{ID-returntotop-organ}}</h5>
-<h4>Otitis media, Treatment failure {{ID-returntotop-organ}}</h4>
+<h5>Otitis media, Treatment failure {{ID-returntotop-organ}}</h5>
-<h4>Parotitis {{ID-returntotop-organ}}</h4>
+<h5>Parotitis {{ID-returntotop-organ}}</h5>
-<h2>Eye</h2>
+<h3>Eye</h3>
-<h4>Conjunctivitis {{ID-returntotop-organ}}</h4>
+<h5>Conjunctivitis {{ID-returntotop-organ}}</h5>
-<h4>Blepharitis {{ID-returntotop-organ}}</h4>
+<h5>Blepharitis {{ID-returntotop-organ}}</h5>
-<h4>Endophthalmitis, bacterial {{ID-returntotop-organ}}</h4>
+<h5>Endophthalmitis, bacterial {{ID-returntotop-organ}}</h5>
-<h4>Endophthalmitis, bleb-related {{ID-returntotop-organ}}</h4>
+<h5>Endophthalmitis, bleb-related {{ID-returntotop-organ}}</h5>
-<h4>Endophthalmitis, candidal {{ID-returntotop-organ}}</h4>
+<h5>Endophthalmitis, candidal {{ID-returntotop-organ}}</h5>
-<h4>Endophthalmitis, chronic {{ID-returntotop-organ}}</h4>
+<h5>Endophthalmitis, chronic {{ID-returntotop-organ}}</h5>
-<h4>Endophthalmitis, mold {{ID-returntotop-organ}}</h4>
+<h5>Endophthalmitis, mold {{ID-returntotop-organ}}</h5>
-<h4>Endophthalmitis, post-cataract surgery, acute {{ID-returntotop-organ}}</h4>
+<h5>Endophthalmitis, post-cataract surgery, acute {{ID-returntotop-organ}}</h5>
-<h4>Endophthalmitis, post-cataract surgery, chronic {{ID-returntotop-organ}}</h4>
+<h5>Endophthalmitis, post-cataract surgery, chronic {{ID-returntotop-organ}}</h5>
-<h4>Endophthalmitis, post-tramatic {{ID-returntotop-organ}}</h4>
+<h5>Endophthalmitis, post-tramatic {{ID-returntotop-organ}}</h5>
-<h4>Keratitis, bacterial {{ID-returntotop-organ}}</h4>
+<h5>Keratitis, bacterial {{ID-returntotop-organ}}</h5>
-<h4>Keratitis, fungal {{ID-returntotop-organ}}</h4>
+<h5>Keratitis, fungal {{ID-returntotop-organ}}</h5>
-<h4>Keratitis, protozoal {{ID-returntotop-organ}}</h4>
+<h5>Keratitis, protozoal {{ID-returntotop-organ}}</h5>
-<h4>Keratitis, viral {{ID-returntotop-organ}}</h4>
+<h5>Keratitis, viral {{ID-returntotop-organ}}</h5>
-<h4>Ocular syphilis {{ID-returntotop-organ}}</h4>
+<h5>Ocular syphilis {{ID-returntotop-organ}}</h5>
-<h4>Ocular toxocariasis {{ID-returntotop-organ}}</h4>
+<h5>Ocular toxocariasis {{ID-returntotop-organ}}</h5>
-<h4>Ocular toxoplasmosis {{ID-returntotop-organ}}</h4>
+<h5>Ocular toxoplasmosis {{ID-returntotop-organ}}</h5>
-<h4>Ocular tuberculosis {{ID-returntotop-organ}}</h4>
+<h5>Ocular tuberculosis {{ID-returntotop-organ}}</h5>
-<h4>Orbital cellulitis {{ID-returntotop-organ}}</h4>
+<h5>Orbital cellulitis {{ID-returntotop-organ}}</h5>
-<h4>Periocular Infection {{ID-returntotop-organ}}</h4>
+<h5>Periocular Infection {{ID-returntotop-organ}}</h5>
-<h4>Retinal necrosis, acute, CMV {{ID-returntotop-organ}}</h4>
+<h5>Retinal necrosis, acute, CMV {{ID-returntotop-organ}}</h5>
-<h4>Retinal necrosis, acute, HSV or VZV {{ID-returntotop-organ}}</h4>
+<h5>Retinal necrosis, acute, HSV or VZV {{ID-returntotop-organ}}</h5>
-<h4>Retinal necrosis, progressive outer, VZV {{ID-returntotop-organ}}</h4>
+<h5>Retinal necrosis, progressive outer, VZV {{ID-returntotop-organ}}</h5>
-<h4>Retinitis, CMV {{ID-returntotop-organ}}</h4>
+<h5>Retinitis, CMV {{ID-returntotop-organ}}</h5>
-<h4>Stye {{ID-returntotop-organ}}</h4>
+<h5>Stye {{ID-returntotop-organ}}</h5>
-<h4>Uveitis, acute anterior {{ID-returntotop-organ}}</h4>
+<h5>Uveitis, acute anterior {{ID-returntotop-organ}}</h5>
-<h4>Uveitis, Lyme disease {{ID-returntotop-organ}}</h4>
+<h5>Uveitis, Lyme disease {{ID-returntotop-organ}}</h5>
-<h2>Upper Respiratory Tract</h2>
+<h3>Upper Respiratory Tract</h3>
-<h4>Epiglottitis {{ID-returntotop-organ}}</h4>
+<h5>Epiglottitis {{ID-returntotop-organ}}</h5>
-<h4>Jugular vein phlebitis {{ID-returntotop-organ}}</h4>
+<h5>Jugular vein phlebitis {{ID-returntotop-organ}}</h5>
-<h4>Laryngitis {{ID-returntotop-organ}}</h4>
+<h5>Laryngitis {{ID-returntotop-organ}}</h5>
-<h4>Lemierre's syndrome {{ID-returntotop-organ}}</h4>
+<h5>Lemierre's syndrome {{ID-returntotop-organ}}</h5>
-<h4>Ludwig's angina {{ID-returntotop-organ}}</h4>
+<h5>Ludwig's angina {{ID-returntotop-organ}}</h5>
-<h4>Parapharyngeal space infection {{ID-returntotop-organ}}</h4>
+<h5>Parapharyngeal space infection {{ID-returntotop-organ}}</h5>
-<h4>Pharyngitis, diphtheria {{ID-returntotop-organ}}</h4>
+<h5>Pharyngitis, diphtheria {{ID-returntotop-organ}}</h5>
-<h4>Pharyngitis, streptococcal {{ID-returntotop-organ}}</h4>
+<h5>Pharyngitis, streptococcal {{ID-returntotop-organ}}</h5>
-<h4>Sinusitis, Acute {{ID-returntotop-organ}}</h4>
+<h5>Sinusitis, Acute {{ID-returntotop-organ}}</h5>
-<h4>Sinusitis, Chronic {{ID-returntotop-organ}}</h4>
+<h5>Sinusitis, Chronic {{ID-returntotop-organ}}</h5>
-<h4>Sinusitis, Post-intubation {{ID-returntotop-organ}}</h4>
+<h5>Sinusitis, Post-intubation {{ID-returntotop-organ}}</h5>
-<h4>Sinusitis, Treatment failure {{ID-returntotop-organ}}</h4>
+<h5>Sinusitis, Treatment failure {{ID-returntotop-organ}}</h5>
-<h4>Stomatitis {{ID-returntotop-organ}}</h4>
+<h5>Stomatitis {{ID-returntotop-organ}}</h5>
-<h4>Stomatitis, aphthous {{ID-returntotop-organ}}</h4>
+<h5>Stomatitis, aphthous {{ID-returntotop-organ}}</h5>
-<h4>Stomatitis, herpetic {{ID-returntotop-organ}}</h4>
+<h5>Stomatitis, herpetic {{ID-returntotop-organ}}</h5>
-<h4>Submandibular space infection {{ID-returntotop-organ}}</h4>
+<h5>Submandibular space infection {{ID-returntotop-organ}}</h5>
-<h4>Tonsillitis {{ID-returntotop-organ}}</h4>
+<h5>Tonsillitis {{ID-returntotop-organ}}</h5>
-<h4>Ulcerative gingivitis {{ID-returntotop-organ}}</h4>
+<h5>Ulcerative gingivitis {{ID-returntotop-organ}}</h5>
-<h4>Vincent's angina {{ID-returntotop-organ}}</h4>
+<h5>Vincent's angina {{ID-returntotop-organ}}</h5>
-<h2>Lower Respiratory Tract</h2>
+<h3>Lower Respiratory Tract</h3>
-<h4>Acute bacterial exacerbations of chronic bronchitis {{ID-returntotop-organ}}</h4>
+<h5>Acute bacterial exacerbations of chronic bronchitis {{ID-returntotop-organ}}</h5>
-<h4>Bronchiectasis {{ID-returntotop-organ}}</h4>
+<h5>Bronchiectasis {{ID-returntotop-organ}}</h5>
-<h4>Bronchiolitis {{ID-returntotop-organ}}</h4>
+<h5>Bronchiolitis {{ID-returntotop-organ}}</h5>
-<h4>Bronchitis {{ID-returntotop-organ}}</h4>
+<h5>Bronchitis {{ID-returntotop-organ}}</h5>
-<h4>Cystic fibrosis {{ID-returntotop-organ}}</h4>
+<h5>Cystic fibrosis {{ID-returntotop-organ}}</h5>
-<h4>Empyema {{ID-returntotop-organ}}</h4>
+<h5>Empyema {{ID-returntotop-organ}}</h5>
-<h4>Influenza {{ID-returntotop-organ}}</h4>
+<h5>Influenza {{ID-returntotop-organ}}</h5>
-<h4>Inhalational anthrax, Prophylaxis {{ID-returntotop-organ}}</h4>
+<h5>Inhalational anthrax, Prophylaxis {{ID-returntotop-organ}}</h5>
-<h4>Inhalational anthrax, Treatment {{ID-returntotop-organ}}</h4>
+<h5>Inhalational anthrax, Treatment {{ID-returntotop-organ}}</h5>
-<h4>Pertussis {{ID-returntotop-organ}}</h4>
+<h5>Pertussis {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Acinetobacter {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Acinetobacter {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Actinomycosis {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Actinomycosis {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Anaerobes {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Anaerobes {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Aspiration pneumonia {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Aspiration pneumonia {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Chlamydophila {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Chlamydophila {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, community-acquired {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, community-acquired {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, concomitant influenza {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, concomitant influenza {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Cytomegalovirus {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Cytomegalovirus {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Haemophilus Influenza {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Haemophilus Influenza {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, health care-associated {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, health care-associated {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, hospital-acquired {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, hospital-acquired {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Klebsiella {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Klebsiella {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Legionella {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Legionella {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Lung abscess {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Lung abscess {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Meliodosis {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Meliodosis {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Moraxella catarrhalis {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Moraxella catarrhalis {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Mycoplasma {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Mycoplasma {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, neutropenic patient {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, neutropenic patient {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Nocardia {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Nocardia {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, post-influenza {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, post-influenza {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Pseuodomonas {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Pseuodomonas {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Staphylococcus aureus {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Staphylococcus aureus {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Stenotrophomonas {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Stenotrophomonas {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Streptococcus pneumoniae {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Streptococcus pneumoniae {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Tularemia {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Tularemia {{ID-returntotop-organ}}</h5>
-<h4>Pneumonia, Yersinia pestis {{ID-returntotop-organ}}</h4>
+<h5>Pneumonia, Yersinia pestis {{ID-returntotop-organ}}</h5>
-<h2>Gastrointestinal and Intraabdominal</h2>
+<h3>Gastrointestinal and Intraabdominal</h3>
-<h4>Anthrax, gastrointestinal {{ID-returntotop-organ}}</h4>
+<h5>Anthrax, gastrointestinal {{ID-returntotop-organ}}</h5>
-<h4>Appendicitis {{ID-returntotop-organ}}</h4>
+<h5>Appendicitis {{ID-returntotop-organ}}</h5>
-<h4>Biliary sepsis {{ID-returntotop-organ}}</h4>
+<h5>Biliary sepsis {{ID-returntotop-organ}}</h5>
-<h4>Cholangitis {{ID-returntotop-organ}}</h4>
+<h5>Cholangitis {{ID-returntotop-organ}}</h5>
-<h4>Cholecystitis {{ID-returntotop-organ}}</h4>
+<h5>Cholecystitis {{ID-returntotop-organ}}</h5>
-<h4>Diverticulitis {{ID-returntotop-organ}}</h4>
+<h5>Diverticulitis {{ID-returntotop-organ}}</h5>
-<h4>Esophagitis {{ID-returntotop-organ}}</h4>
+<h5>Esophagitis {{ID-returntotop-organ}}</h5>
-<h4>Hepatic abscess {{ID-returntotop-organ}}</h4>
+<h5>Hepatic abscess {{ID-returntotop-organ}}</h5>
-<h4>Hepatitis A {{ID-returntotop-organ}}</h4>
+<h5>Hepatitis A {{ID-returntotop-organ}}</h5>
-<h4>Hepatitis B {{ID-returntotop-organ}}</h4>
+<h5>Hepatitis B {{ID-returntotop-organ}}</h5>
-<h4>Hepatitis C {{ID-returntotop-organ}}</h4>
+<h5>Hepatitis C {{ID-returntotop-organ}}</h5>
-<h4>Hepatitis D {{ID-returntotop-organ}}</h4>
+<h5>Hepatitis D {{ID-returntotop-organ}}</h5>
-<h4>Hepatitis E {{ID-returntotop-organ}}</h4>
+<h5>Hepatitis E {{ID-returntotop-organ}}</h5>
-<h4>Infectious diarrhea {{ID-returntotop-organ}}</h4>
+<h5>Infectious diarrhea {{ID-returntotop-organ}}</h5>
-<h4>Leptospirosis {{ID-returntotop-organ}}</h4>
+<h5>Leptospirosis {{ID-returntotop-organ}}</h5>
-<h4>Pancreatitis {{ID-returntotop-organ}}</h4>
+<h5>Pancreatitis {{ID-returntotop-organ}}</h5>
-<h4>Peliosis hepatitis {{ID-returntotop-organ}}</h4>
+<h5>Peliosis hepatitis {{ID-returntotop-organ}}</h5>
-<h4>Peptic ulcer disease {{ID-returntotop-organ}}</h4>
+<h5>Peptic ulcer disease {{ID-returntotop-organ}}</h5>
-<h4>Peritonitis, secondary to bowel perforation {{ID-returntotop-organ}}</h4>
+<h5>Peritonitis, secondary to bowel perforation {{ID-returntotop-organ}}</h5>
-<h4>Peritonitis, secondary to dialysis {{ID-returntotop-organ}}</h4>
+<h5>Peritonitis, secondary to dialysis {{ID-returntotop-organ}}</h5>
-<h4>Peritonitis, secondary to ruptured appendix {{ID-returntotop-organ}}</h4>
+<h5>Peritonitis, secondary to ruptured appendix {{ID-returntotop-organ}}</h5>
-<h4>Peritonitis, secondary to ruptured diverticula {{ID-returntotop-organ}}</h4>
+<h5>Peritonitis, secondary to ruptured diverticula {{ID-returntotop-organ}}</h5>
-<h4>Peritonitis, spontaneous bacterial {{ID-returntotop-organ}}</h4>
+<h5>Peritonitis, spontaneous bacterial {{ID-returntotop-organ}}</h5>
-<h4>Post-transplant infected biloma {{ID-returntotop-organ}}</h4>
+<h5>Post-transplant infected biloma {{ID-returntotop-organ}}</h5>
-<h4>Splenic abscess {{ID-returntotop-organ}}</h4>
+<h5>Splenic abscess {{ID-returntotop-organ}}</h5>
-<h4>Tropical sprue {{ID-returntotop-organ}}</h4>
+<h5>Tropical sprue {{ID-returntotop-organ}}</h5>
-<h4>Typhlitis {{ID-returntotop-organ}}</h4>
+<h5>Typhlitis {{ID-returntotop-organ}}</h5>
-<h4>Variceal bleeding, prophylaxis {{ID-returntotop-organ}}</h4>
+<h5>Variceal bleeding, prophylaxis {{ID-returntotop-organ}}</h5>
-<h4>Whipple's disease {{ID-returntotop-organ}}</h4>
+<h5>Whipple's disease {{ID-returntotop-organ}}</h5>
-<h2>Genitourinary</h2>
+<h3>Genitourinary</h3>
-<h4>Asymptomatic bacteriuria {{ID-returntotop-organ}}</h4>
+<h5>Asymptomatic bacteriuria {{ID-returntotop-organ}}</h5>
-<h4>Bacterial vaginosis {{ID-returntotop-organ}}</h4>
+<h5>Bacterial vaginosis {{ID-returntotop-organ}}</h5>
-<h4>Cervicitis {{ID-returntotop-organ}}</h4>
+<h5>Cervicitis {{ID-returntotop-organ}}</h5>
-<h4>Chancroid {{ID-returntotop-organ}}</h4>
+<h5>Chancroid {{ID-returntotop-organ}}</h5>
-<h4>Chlamydial infections {{ID-returntotop-organ}}</h4>
+<h5>Chlamydial infections {{ID-returntotop-organ}}</h5>
-<h4>Chorioamnionitis {{ID-returntotop-organ}}</h4>
+<h5>Chorioamnionitis {{ID-returntotop-organ}}</h5>
-<h4>Cystitis {{ID-returntotop-organ}}</h4>
+<h5>Cystitis {{ID-returntotop-organ}}</h5>
-<h4>Ectoparasitic infections {{ID-returntotop-organ}}</h4>
+<h5>Ectoparasitic infections {{ID-returntotop-organ}}</h5>
-<h4>Epididymitis {{ID-returntotop-organ}}</h4>
+<h5>Epididymitis {{ID-returntotop-organ}}</h5>
-<h4>Genital herpes {{ID-returntotop-organ}}</h4>
+<h5>Genital herpes {{ID-returntotop-organ}}</h5>
-<h4>Gonococcal infections {{ID-returntotop-organ}}</h4>
+<h5>Gonococcal infections {{ID-returntotop-organ}}</h5>
-<h4>Granuloma Inguinale {{ID-returntotop-organ}}</h4>
+<h5>Granuloma Inguinale {{ID-returntotop-organ}}</h5>
-<h4>Human papillomavirus infection {{ID-returntotop-organ}}</h4>
+<h5>Human papillomavirus infection {{ID-returntotop-organ}}</h5>
-<h4>Lymphogranuloma venereum {{ID-returntotop-organ}}</h4>
+<h5>Lymphogranuloma venereum {{ID-returntotop-organ}}</h5>
-<h4>Pelvic inflammatory disease {{ID-returntotop-organ}}</h4>
+<h5>Pelvic inflammatory disease {{ID-returntotop-organ}}</h5>
-<h4>Proctocolitis {{ID-returntotop-organ}}</h4>
+<h5>Proctocolitis {{ID-returntotop-organ}}</h5>
-<h4>Prostatitis, acute bacterial {{ID-returntotop-organ}}</h4>
+<h5>Prostatitis, acute bacterial {{ID-returntotop-organ}}</h5>
-<h4>Prostatitis, chronic bacterial {{ID-returntotop-organ}}</h4>
+<h5>Prostatitis, chronic bacterial {{ID-returntotop-organ}}</h5>
-<h4>Pyelonephritis {{ID-returntotop-organ}}</h4>
+<h5>Pyelonephritis {{ID-returntotop-organ}}</h5>
-<h4>Syphilis {{ID-returntotop-organ}}</h4>
+<h5>Syphilis {{ID-returntotop-organ}}</h5>
-<h4>Urethritis {{ID-returntotop-organ}}</h4>
+<h5>Urethritis {{ID-returntotop-organ}}</h5>
-<h4>Vulvovaginal candidiasis {{ID-returntotop-organ}}</h4>
+<h5>Vulvovaginal candidiasis {{ID-returntotop-organ}}</h5>
-<h2>Musculoskeletal</h2>
+<h3>Musculoskeletal</h3>
-<h4>Bursitis {{ID-returntotop-organ}}</h4>
+<h5>Bursitis {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, candidal {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, candidal {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, chronic {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, chronic {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, contiguous with vascular insufficiency {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, contiguous with vascular insufficiency {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, contiguous without vascular insufficiency {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, contiguous without vascular insufficiency {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, diabetic foot {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, diabetic foot {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, foot bone {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, foot bone {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, foot puncture wound {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, foot puncture wound {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, hematogenous {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, hematogenous {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, hemoglobinopathy {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, hemoglobinopathy {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, prosthetic joint infection {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, prosthetic joint infection {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, spinal implant {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, spinal implant {{ID-returntotop-organ}}</h5>
-<h4>Osteomyelitis, sternal {{ID-returntotop-organ}}</h4>
+<h5>Osteomyelitis, sternal {{ID-returntotop-organ}}</h5>
-<h4>Reactive arthritis, post-streptococcal arthritis {{ID-returntotop-organ}}</h4>
+<h5>Reactive arthritis, post-streptococcal arthritis {{ID-returntotop-organ}}</h5>
-<h4>Reactive arthritis, Reiter's syndrome {{ID-returntotop-organ}}</h4>
+<h5>Reactive arthritis, Reiter's syndrome {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, brucellosis {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, brucellosis {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, candidal {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, candidal {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, gonococcal {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, gonococcal {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, Gram-negative bacilli {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, Gram-negative bacilli {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, Histoplasmosis {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, Histoplasmosis {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, Lyme disease {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, Lyme disease {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, Mycobacterium tuberculosis {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, Mycobacterium tuberculosis {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, pneumococcal {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, pneumococcal {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, post-intraarticular injection {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, post-intraarticular injection {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, staphylococcal {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, staphylococcal {{ID-returntotop-organ}}</h5>
-<h4>Septic arthritis, streptococcal {{ID-returntotop-organ}}</h4>
+<h5>Septic arthritis, streptococcal {{ID-returntotop-organ}}</h5>
-<h2>Skin and Soft Tissues</h2>
+<h3>Skin and Soft Tissues</h3>
-<h4>Acne vulgaris {{ID-returntotop-organ}}</h4>
+<h5>Acne vulgaris {{ID-returntotop-organ}}</h5>
-<h4>Acne rosacea {{ID-returntotop-organ}}</h4>
+<h5>Acne rosacea {{ID-returntotop-organ}}</h5>
-<h4>Anthrax, cutaneous {{ID-returntotop-organ}}</h4>
+<h5>Anthrax, cutaneous {{ID-returntotop-organ}}</h5>
-<h4>Bacillary angiomatosis {{ID-returntotop-organ}}</h4>
+<h5>Bacillary angiomatosis {{ID-returntotop-organ}}</h5>
-<h4>Bite wounds {{ID-returntotop-organ}}</h4>
+<h5>Bite wounds {{ID-returntotop-organ}}</h5>
-<h4>Bubonic plague {{ID-returntotop-organ}}</h4>
+<h5>Bubonic plague {{ID-returntotop-organ}}</h5>
-<h4>Carbuncle {{ID-returntotop-organ}}</h4>
+<h5>Carbuncle {{ID-returntotop-organ}}</h5>
-<h4>Cat scratch disease {{ID-returntotop-organ}}</h4>
+<h5>Cat scratch disease {{ID-returntotop-organ}}</h5>
-<h4>Cellulitis {{ID-returntotop-organ}}</h4>
+<h5>Cellulitis {{ID-returntotop-organ}}</h5>
-<h4>Ecthyma {{ID-returntotop-organ}}</h4>
+<h5>Ecthyma {{ID-returntotop-organ}}</h5>
-<h4>Erysipelas {{ID-returntotop-organ}}</h4>
+<h5>Erysipelas {{ID-returntotop-organ}}</h5>
-<h4>Erysipeloid {{ID-returntotop-organ}}</h4>
+<h5>Erysipeloid {{ID-returntotop-organ}}</h5>
-<h4>Erythrasma {{ID-returntotop-organ}}</h4>
+<h5>Erythrasma {{ID-returntotop-organ}}</h5>
-<h4>Fournier gangrene {{ID-returntotop-organ}}</h4>
+<h5>Fournier gangrene {{ID-returntotop-organ}}</h5>
-<h4>Furuncle {{ID-returntotop-organ}}</h4>
+<h5>Furuncle {{ID-returntotop-organ}}</h5>
-<h4>Gas gangrene {{ID-returntotop-organ}}</h4>
+<h5>Gas gangrene {{ID-returntotop-organ}}</h5>
-<h4>Glanders {{ID-returntotop-organ}}</h4>
+<h5>Glanders {{ID-returntotop-organ}}</h5>
-<h4>Impetigo {{ID-returntotop-organ}}</h4>
+<h5>Impetigo {{ID-returntotop-organ}}</h5>
-<h4>Lyme disease, cutaneous {{ID-returntotop-organ}}</h4>
+<h5>Lyme disease, cutaneous {{ID-returntotop-organ}}</h5>
-<h4>Mastitis {{ID-returntotop-organ}}</h4>
+<h5>Mastitis {{ID-returntotop-organ}}</h5>
-<h4>Necrotizing fasciitis {{ID-returntotop-organ}}</h4>
+<h5>Necrotizing fasciitis {{ID-returntotop-organ}}</h5>
-<h4>Pilonidal cyst {{ID-returntotop-organ}}</h4>
+<h5>Pilonidal cyst {{ID-returntotop-organ}}</h5>
-<h4>Pyomyositis {{ID-returntotop-organ}}</h4>
+<h5>Pyomyositis {{ID-returntotop-organ}}</h5>
-<h4>Seborrheic dermatitis {{ID-returntotop-organ}}</h4>
+<h5>Seborrheic dermatitis {{ID-returntotop-organ}}</h5>
-<h4>Skin and soft tissue infection in neutropenic fever {{ID-returntotop-organ}}</h4>
+<h5>Skin and soft tissue infection in neutropenic fever {{ID-returntotop-organ}}</h5>
-<h4>Skin and soft tissue infection in cellular immunodeficiency {{ID-returntotop-organ}}</h4>
+<h5>Skin and soft tissue infection in cellular immunodeficiency {{ID-returntotop-organ}}</h5>
-<h4>Surgical site infection {{ID-returntotop-organ}}</h4>
+<h5>Surgical site infection {{ID-returntotop-organ}}</h5>
-<h4>Tularemia {{ID-returntotop-organ}}</h4>
+<h5>Tularemia {{ID-returntotop-organ}}</h5>
-<h4>Vascular insufficieny ulcer {{ID-returntotop-organ}}</h4>
+<h5>Vascular insufficieny ulcer {{ID-returntotop-organ}}</h5>
-<h4>Vibrio infection {{ID-returntotop-organ}}</h4>
+<h5>Vibrio infection {{ID-returntotop-organ}}</h5>
-<h4>Wound infection {{ID-returntotop-organ}}</h4>
+<h5>Wound infection {{ID-returntotop-organ}}</h5>
-<h4>Yaws {{ID-returntotop-organ}}</h4>
+<h5>Yaws {{ID-returntotop-organ}}</h5>
-<h2>Systemic</h2>
+<h3>Systemic</h3>
-<h4>Anaplasmosis {{ID-returntotop-organ}}</h4>
+<h5>Anaplasmosis {{ID-returntotop-organ}}</h5>
-<h4>Babesiosis {{ID-returntotop-organ}}</h4>
+<h5>Babesiosis {{ID-returntotop-organ}}</h5>
-<h4>Bartonella {{ID-returntotop-organ}}</h4>
+<h5>Bartonella {{ID-returntotop-organ}}</h5>
-<h4>Botulism {{ID-returntotop-organ}}</h4>
+<h5>Botulism {{ID-returntotop-organ}}</h5>
-<h4>Boutonneuese fever {{ID-returntotop-organ}}</h4>
+<h5>Boutonneuese fever {{ID-returntotop-organ}}</h5>
-<h4>Brucellosis {{ID-returntotop-organ}}</h4>
+<h5>Brucellosis {{ID-returntotop-organ}}</h5>
-<h4>Diptheria {{ID-returntotop-organ}}</h4>
+<h5>Diptheria {{ID-returntotop-organ}}</h5>
-<h4>Ehrlichiolsis {{ID-returntotop-organ}}</h4>
+<h5>Ehrlichiolsis {{ID-returntotop-organ}}</h5>
-<h4>Febrile neutropenia, prophylaxis {{ID-returntotop-organ}}</h4>
+<h5>Febrile neutropenia, prophylaxis {{ID-returntotop-organ}}</h5>
-<h4>Febrile neutropenia, treatment {{ID-returntotop-organ}}</h4>
+<h5>Febrile neutropenia, treatment {{ID-returntotop-organ}}</h5>
-<h4>Kawasaki syndrome {{ID-returntotop-organ}}</h4>
+<h5>Kawasaki syndrome {{ID-returntotop-organ}}</h5>
-<h4>Leptospirosis {{ID-returntotop-organ}}</h4>
+<h5>Leptospirosis {{ID-returntotop-organ}}</h5>
-<h4>Lymphadenitis {{ID-returntotop-organ}}</h4>
+<h5>Lymphadenitis {{ID-returntotop-organ}}</h5>
-<h4>Lymphangitis {{ID-returntotop-organ}}</h4>
+<h5>Lymphangitis {{ID-returntotop-organ}}</h5>
-<h4>Relapsing fever {{ID-returntotop-organ}}</h4>
+<h5>Relapsing fever {{ID-returntotop-organ}}</h5>
-<h4>Rocky Mountain spotted fever {{ID-returntotop-organ}}</h4>
+<h5>Rocky Mountain spotted fever {{ID-returntotop-organ}}</h5>
-<h4>Salmonella bacteremia {{ID-returntotop-organ}}</h4>
+<h5>Salmonella bacteremia {{ID-returntotop-organ}}</h5>
-<h4>Sepsis {{ID-returntotop-organ}}</h4>
+<h5>Sepsis {{ID-returntotop-organ}}</h5>
-<h4>Staphylococcal toxic shock syndrome {{ID-returntotop-organ}}</h4>
+<h5>Staphylococcal toxic shock syndrome {{ID-returntotop-organ}}</h5>
-<h4>Streptococcal toxic shock syndrome {{ID-returntotop-organ}}</h4>
+<h5>Streptococcal toxic shock syndrome {{ID-returntotop-organ}}</h5>
-<h4>Tetanus {{ID-returntotop-organ}}</h4>
+<h5>Tetanus {{ID-returntotop-organ}}</h5>
-<h4>Tularemia {{ID-returntotop-organ}}</h4>
+<h5>Tularemia {{ID-returntotop-organ}}</h5>
-<h4>Typhoid fever {{ID-returntotop-organ}}</h4>
+<h5>Typhoid fever {{ID-returntotop-organ}}</h5>
-<h4>Typhus, louse-borne {{ID-returntotop-organ}}</h4>
+<h5>Typhus, louse-borne {{ID-returntotop-organ}}</h5>
-<h4>Typhus, murine {{ID-returntotop-organ}}</h4>
+<h5>Typhus, murine {{ID-returntotop-organ}}</h5>
-<h4>Typhus, scrub {{ID-returntotop-organ}}</h4>
+<h5>Typhus, scrub {{ID-returntotop-organ}}</h5>